Skip to main content

Penn Capital Management Company, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1158202 PHILADELPHIA, PA

Position in NBIX

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$1,786,524
+$1,395,836 QoQ
Shares Held
10,600
+224.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#329
of 772 holders
Holding Since
Jun 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Penn Capital Management Company, LLC holds $80,501,316 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NBIX
Neurocrine Biosciences Inc
This page
10,600 $1,786,524

All Filings in NBIX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,786,524 10,600
2022-12-31 $390,688 3,271
2022-09-30 $356,440 3,356
2022-06-30 $342,154 3,510
2022-03-31 $334,406 3,567
2021-12-31 $244,948 2,876
2021-09-30 $274,878 2,866
2021-06-30 $293,419 3,015
2021-03-31 $295,931 3,043
2020-12-31 $292,725 3,054
2020-09-30 $2,159,272 22,455
2020-06-30 $1,755,946 14,393